Alka-seltzer Plus Severe Cold And Flu Powerfast Fizz Tablet, Effervescent
NDC Package 67751-217-01
Package Information
Alka-seltzer Plus Severe Cold And Flu Powerfast Fizz (chlorpheniramine maleate, acetaminophen, phenylephrine hydrochloride, dextromethorphan hydrobromide) tablets is uses · temporarily relieves these symptoms due to a cold or flu:· minor aches and pains · headache · cough· sore throat · runny nose · sneezing· nasal and sinus congestion· temporarily reduces fever. This formulation utilizes a tablet, effervescent delivery system. Marketed by Navajo Manufacturing Company Inc., this product is identified by NDC 67751-217 and is authorized under FDA application M012.
Identification & Billing
- RxCUI: 1536477 - acetaminophen 250 MG / chlorpheniramine maleate 2 MG / dextromethorphan HBr 10 MG / phenylephrine HCl 5 MG Effervescent Oral Tablet
- RxCUI: 1536477 - acetaminophen 250 MG / chlorpheniramine maleate 2 MG / dextromethorphan hydrobromide 10 MG / phenylephrine hydrochloride 5 MG Effervescent Oral Tablet
- RxCUI: 1536477 - APAP 250 MG / Chlorpheniramine Maleate 2 MG / Dextromethorphan Hydrobromide 10 MG / Phenylephrine Hydrochloride 5 MG Effervescent Oral Tablet
Clinical Specifications
- Adrenergic alpha1-Agonists - [MoA] (Mechanism of Action)
- Histamine H1 Receptor Antagonists - [MoA] (Mechanism of Action)
- Histamine-1 Receptor Antagonist - [EPC] (Established Pharmacologic Class)
- Sigma-1 Agonist - [EPC] (Established Pharmacologic Class)
- Sigma-1 Receptor Agonists - [MoA] (Mechanism of Action)
- Uncompetitive N-methyl-D-aspartate Receptor Antagonist - [EPC] (Established Pharmacologic Class)
- Uncompetitive NMDA Receptor Antagonists - [MoA] (Mechanism of Action)
- alpha-1 Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 67751 - Navajo Manufacturing Company Inc.
- 67751-217 - Alka-seltzer Plus Severe Cold And Flu Powerfast Fizz
- 67751-217-01 - 1 POUCH in 1 CARTON / 1 TABLET, EFFERVESCENT in 1 POUCH
- 67751-217 - Alka-seltzer Plus Severe Cold And Flu Powerfast Fizz
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (67751-217). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 67751-217-01 identifies a specific commercial package of 1 pouch in 1 carton / 1 tablet, effervescent in 1 pouch of Alka-seltzer Plus Severe Cold And Flu Powerfast Fizz, a human over the counter drug labeled by Navajo Manufacturing Company Inc.. This tablet, effervescent is formulated for oral use and contains acetaminophen; chlorpheniramine maleate; dextromethorphan hydrobromide; phenylephrine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Navajo Manufacturing Company Inc. on June 01, 2022. The current certification is valid through December 31, 2026.
How is this Navajo Manufacturing Company Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 67751021701. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.